RXPC

 
Common Stock
OTC Pink No Information
Contact Info
  • 2492 Walnut Avenue
  • Suite 100
  • Tustin, CA 92780-7039

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Dec 31, 2011 10-K
CIK 0000838879
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1989
Employees 13 a/o Jun 09, 2011
Company Officers/Contacts
Douglas MacLellan CEO
Akio Ariura CFO, COO
Company Directors
Douglas MacLellan Chairman
Robert M. Beart
Michael Boswell
Leonard M.J. Reyno
Robert L. Rooks
Company Notes
  • Note = Company delisted from NYSE Amex on 06/23/11
  • Formerly=AMDL, Inc. until 9-2009
  • Note=6-89 State of incorporation Colorado changed to Delaware
  • Formerly=California Ventures, Inc. to 6-89
Service Providers
Accounting/Auditing Firm
KMJ Corbin & Company
555 Anton Blvd
Suite 1000
Costa Mesa, 92646
United States

Legal Counsel
Hunter Taubman Weiss LLP
17 State Street.
20th FL
New York, NY, 10004
United States

Investor Relations Firm
Not Available
RXPC Security Details
Share Structure
Market Value1 $2,991 a/o Apr 17, 2014
Shares Outstanding 29,911,602 a/o Feb 10, 2012
Float Not Available
Authorized Shares 200,000,000 a/o Jun 09, 2011
Par Value 0.001
Shareholders
Shareholders of Record 801 a/o May 25, 2011
Short Selling Data
Short Interest 5 (-100%)
Mar 31, 2014
Significant Failures to Deliver No
Transfer Agent(s)
Corporate Stock Transfer, Inc.

1Market Value calculated only for respective security